Your browser doesn't support javascript.
loading
An engineered N-acyltransferase-LOV2 domain fusion protein enables light-inducible allosteric control of enzymatic activity.
Reynolds, J A; Vishweshwaraiah, Y L; Chirasani, V R; Pritchard, J R; Dokholyan, N V.
Afiliação
  • Reynolds JA; Department of Biomedical Engineering, Penn State University, University Park, Pennsylvania, USA.
  • Vishweshwaraiah YL; Department of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  • Chirasani VR; Department of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  • Pritchard JR; Department of Biomedical Engineering, Penn State University, University Park, Pennsylvania, USA.
  • Dokholyan NV; Department of Biomedical Engineering, Penn State University, University Park, Pennsylvania, USA; Department of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania, USA; Department of Biochemistry & Molecular Biology, Penn State College of Medicine, Hershey, Pennsylvania, USA; Dep
J Biol Chem ; 299(4): 103069, 2023 04.
Article em En | MEDLINE | ID: mdl-36841477
ABSTRACT
Transferases are ubiquitous across all known life. While much work has been done to understand and describe these essential enzymes, there have been minimal efforts to exert tight and reversible control over their activity for various biotechnological applications. Here, we apply a rational, computation-guided methodology to design and test a transferase-class enzyme allosterically regulated by light-oxygen-voltage 2 sensing domain. We utilize computational techniques to determine the intrinsic allosteric networks within N-acyltransferase (Orf11/∗Dbv8) and identify potential allosteric sites on the protein's surface. We insert light-oxygen-voltage 2 sensing domain at the predicted allosteric site, exerting reversible control over enzymatic activity. We demonstrate blue-light regulation of N-acyltransferase (Orf11/∗Dbv8) function. Our study for the first time demonstrates optogenetic regulation of a transferase-class enzyme as a proof-of-concept for controllable transferase design. This successful design opens the door for many future applications in metabolic engineering and cellular programming.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Aciltransferases Idioma: En Revista: J Biol Chem Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Aciltransferases Idioma: En Revista: J Biol Chem Ano de publicação: 2023 Tipo de documento: Article